ES388135A2 - Procedimiento para la obtencion de lactamas sustituidas en el nitrogeno. - Google Patents

Procedimiento para la obtencion de lactamas sustituidas en el nitrogeno.

Info

Publication number
ES388135A2
ES388135A2 ES388135A ES388135A ES388135A2 ES 388135 A2 ES388135 A2 ES 388135A2 ES 388135 A ES388135 A ES 388135A ES 388135 A ES388135 A ES 388135A ES 388135 A2 ES388135 A2 ES 388135A2
Authority
ES
Spain
Prior art keywords
alkenyl
alkyl
alkynyl radical
cycloalkyl
represents hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES388135A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of ES388135A2 publication Critical patent/ES388135A2/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES388135A 1970-02-13 1971-02-10 Procedimiento para la obtencion de lactamas sustituidas en el nitrogeno. Expired ES388135A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB697870A GB1309692A (en) 1970-02-13 1970-02-13 N-substituted lactams

Publications (1)

Publication Number Publication Date
ES388135A2 true ES388135A2 (es) 1973-05-01

Family

ID=9824325

Family Applications (1)

Application Number Title Priority Date Filing Date
ES388135A Expired ES388135A2 (es) 1970-02-13 1971-02-10 Procedimiento para la obtencion de lactamas sustituidas en el nitrogeno.

Country Status (15)

Country Link
JP (2) JPS535301B1 (es)
BE (1) BE762728R (es)
CH (1) CH530395A (es)
CS (2) CS167911B2 (es)
DE (1) DE2106418C2 (es)
DK (1) DK137451B (es)
ES (1) ES388135A2 (es)
FI (1) FI54916C (es)
FR (1) FR2081508B2 (es)
GB (1) GB1309692A (es)
MY (1) MY7400072A (es)
NL (1) NL168830C (es)
SU (2) SU508186A3 (es)
YU (2) YU34876B (es)
ZA (1) ZA71877B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
GB1583871A (en) * 1976-10-19 1981-02-04 Ucb Sa Anti-aggregants
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
DE2960194D1 (en) 1978-05-08 1981-04-16 Ucb Sa Lactam-n-acetic acids, their amides, process for their preparation and therapeutic compositions containing them
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB8412358D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
US4804400A (en) * 1986-09-12 1989-02-14 Ciba-Geigy Corporation N-phenyl-maleimides and herbicidal and plant growth regulating methods of use thereof
GB8827389D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide
TW544311B (en) * 1998-08-06 2003-08-01 Daiichi Seiyaku Co Therapeutic or preventive agent for intractable epilepsies
GB0004297D0 (en) 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6686477B2 (en) 2000-09-29 2004-02-03 Eastman Chemical Company Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
EP1395560A1 (en) 2001-05-23 2004-03-10 Ucb, S.A. 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders
ATE410412T1 (de) 2001-08-10 2008-10-15 Ucb Pharma Sa Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
CA2461961A1 (en) * 2001-10-08 2003-04-17 Ucb, S.A. Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders
EP1517893A2 (en) 2003-02-03 2005-03-30 Teva Pharmaceutical Industries Limited Process for producing levetiracetam
ES2214147B1 (es) 2003-02-28 2005-10-01 Farma-Lepori S.A. Procedimiento de obtencion de un agente antiepileptico.
US7531673B2 (en) 2004-02-18 2009-05-12 Dr. Reddy's Laboratories Limited Preparation of amino acid amides
CA2488325C (en) 2004-11-22 2010-08-24 Apotex Pharmachem Inc. Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
US20080146819A1 (en) * 2005-03-10 2008-06-19 Rubamin Limited Process for Preparing Levetiracetam
CA2610695A1 (en) 2005-06-01 2006-12-07 Ucb Pharma, S.A. 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
EP2147911A1 (en) 2008-07-24 2010-01-27 ZaCh System S.p.A. Process for the preparation of levetiracetam
CN102227217A (zh) 2008-10-16 2011-10-26 约翰斯.霍普金斯大学 改善认知功能的方法和组合物
US8785661B2 (en) 2009-05-13 2014-07-22 Nektar Therapeutics Oligome-containing pyrrolidine compounds
US7939676B2 (en) 2009-09-17 2011-05-10 Zach System S.P.A. Process for the preparation of levetiracetam
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
DK2968220T3 (da) 2013-03-15 2021-06-14 Agenebio Inc Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
WO2015110435A1 (en) 2014-01-21 2015-07-30 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
CN104059010A (zh) * 2014-06-12 2014-09-24 浙江华海药业股份有限公司 一种制备2-(2-氧代吡咯烷-1-基)-丁酸酯的方法
CN106591179B (zh) * 2016-12-05 2018-07-03 长兴制药股份有限公司 甲基包囊菌及其在选择性拆分制备(S)-α-乙基-2-氧-1-吡咯烷乙酸盐上的应用
RU2663899C1 (ru) * 2017-07-19 2018-08-13 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" Способ получения 1-карбамоилметил-4-фенил-2-пирролидона
US11384050B1 (en) 2021-02-03 2022-07-12 Vitaworks Ip, Llc Method for preparing levetiracetam and intermediates thereof
WO2024039886A1 (en) 2022-08-19 2024-02-22 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams

Also Published As

Publication number Publication date
JPS53130656A (en) 1978-11-14
DK137451B (da) 1978-03-06
FI54916B (fi) 1978-12-29
DE2106418C2 (de) 1983-12-22
DE2106418A1 (de) 1971-08-19
FR2081508B2 (es) 1975-06-06
CS167911B2 (es) 1976-05-28
DK137451C (es) 1978-07-24
SU508186A3 (ru) 1976-03-25
NL7101697A (es) 1971-08-17
CH530395A (fr) 1972-11-15
JPS535301B1 (es) 1978-02-25
SU508185A3 (ru) 1976-03-25
ZA71877B (en) 1971-10-27
NL168830B (nl) 1981-12-16
GB1309692A (en) 1973-03-14
BE762728R (fr) 1971-08-10
JPS5420491B2 (es) 1979-07-23
NL168830C (nl) 1982-05-17
FI54916C (fi) 1979-04-10
YU30671A (en) 1979-10-31
YU144578A (en) 1982-10-31
MY7400072A (en) 1974-12-31
YU34876B (en) 1980-04-30
FR2081508A2 (es) 1971-12-03
CS167912B2 (es) 1976-05-28

Similar Documents

Publication Publication Date Title
ES388135A2 (es) Procedimiento para la obtencion de lactamas sustituidas en el nitrogeno.
ES399497A1 (es) Procedimiento para la obtencion de p-mentano - 3 - carbosa-midas n - sustituidas.
ES450643A1 (es) Procedimiento para la preparacion de derivados de pirrolidi-na.
ES330164A1 (es) Un procedimiento para preparar una triamida de un acido de fosforo.
ES406550A1 (es) Procedimiento para la obtencion de derivados de la oxadia- zolona.
ES463424A1 (es) Procedimiento de preparacion de lactamas sustituidas en n.
ES395766A1 (es) Procedimiento para la obtencion de derivados de la hidan- toina.
ES388013A1 (es) Procedimiento para la obtencion de sulfenamidas del acido 2-formilpropil-sulfenico-(2).
ES281085A1 (es) Procedimiento para la obtención de nuevas succinimidas
ES404315A1 (es) Un procedimiento de preparacion de un derivado de nitrosou-rea.
ES400414A1 (es) Procedimiento para la preparacion de derivados de piperidi-na n-sustituidos y su utilizacion como estabilizadores.
ES288799A1 (es) Procedimiento para preparar nuevos quelatos metálicos con grupos epóxidos
ES281404A1 (es) Procedimiento para la preparación de difenilalquilaminas
ES396340A1 (es) Un procedimiento de preparacion de oxaziridinas.
ES355907A3 (es) Procedimiento para preparar 3-imino-benzisotiazolinas sus- tituidas en el atomo de nitrogeno.
ES474461A1 (es) Procedimiento de obtencion de amidas desoxivincaminicas.
ES413044A1 (es) Procedimiento de preparacion de fenotiazinas.
ES374134A1 (es) Procedimiento para la preparacion de nuevas diaminas dipri-marias.
ES388398A1 (es) Procedimiento para la obtencion de aminas sustituidas.
ES330524A1 (es) Procedimiento para la preparacion de un antibiotico.
ES461846A2 (es) Un procedimiento para la preparacion de acidos carboxilicos alfa-cetonicos.
ES458169A1 (es) Procedimiento para preparar naftilmetilaminas.
ES271075A1 (es) Procedimiento de obtención de derivados de ácido lisérgico y sus sales ácidas de adición
ES424470A1 (es) Un procedimiento para la preparacion de compuestos hetero- ciclicos del tipo de los pinanopirazoles.
ES396679A1 (es) Procedimiento para la deshidrociclizacion oxidiativa de li-minas.